Clinical Trial Update: Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing rapid-acting insulin aspart versus faster-acting aspart within a single-hormone closed-loop system for regulating postprandial glucose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• insulin aspart (rapid-acting) (insulin aspart)

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: WITHDRAWN